Abstract
Three-dimensional models can provide another experimental system for investigating many aspects of tumor biology, particularly of cell death and survival. These models, both in vitro and ex vivo, may be ideally suited for studying mesothelioma. Here we discuss the reports that are currently available on this subject and highlight areas in which 3D biology may provide insights into the mechanisms of cell death and survival in mesothelioma. It has long been known that single cells or monolayers are more sensitive to cell death than 3D aggregates or spheroids, which acquire resistance called “multicellular resistance.” Possible survival mechanisms that have been studied using multicellular spheroids (in vitro) and tumor fragment spheroids (ex vivo) include growth factor pathways, calcium-dependent cell-cell adhesion, resistance to drug penetrance, gene expression, epigenetics, Bcl-2 anti-apoptotic family expression, and autophagy. In general, cells in a 3D setting show many differences compared to the same cells in a 2D monolayer. Many of these differences appear to contribute to cell survival. In many cases, these features can be shown to be more similar to those in the actual tumor. Thus, whereas 3D studies offer more challenges for study, they offer the opportunity for new insights not possible in 2D studies. They may thus offer an intermediate model between the monolayer and in vivo studies and hopefully lead to discoveries that can be tested in clinical trials to benefit patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aceto N, Bardia A, Miyamoto DT et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158:1110–1122
Barbone D, Cheung P, Battula S et al (2012) Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One 7:e52753
Barbone D, Follo C, Echeverry N et al (2015) Autophagy correlates with the therapeutic responsiveness of malignant pleural mesothelioma in 3D models. PLoS One 10:e0134825
Barbone D, Ryan JA, Kolhatkar N et al (2011) The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance. Cell Death Dis 2:e174
Barbone D, Van Dam L, Follo C et al (2016) Analysis of gene expression in 3D spheroids highlights a survival role for ASS1 in mesothelioma. PLoS One 11:e0150044
Barbone D, Yang TM, Morgan JR et al (2008) Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 283:13021–13030
Bidlingmaier S, He J, Wang Y et al (2009) Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res 69:1570–1577
Birgersdotter A, Baumforth KR, Porwit A et al (2007) Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern. Leuk Lymphoma 48:2042–2053
Birgersdotter A, Sandberg R, Ernberg I (2005) Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 15:405–412
Bobek V, Kacprzak G, Rzechonek A et al (2014) Detection and cultivation of circulating tumor cells in malignant pleural mesothelioma. Anticancer Res 34:2565–2569
Broaddus VC, Dansen TB, Abayasiriwardana KS et al (2005) Bid mediates apoptotic synergy between TRAIL and DNA damage. J Biol Chem 280:12486–12493
Cang S, Iragavarapu C, Savooji J et al (2015) ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J Hematol Oncol 8:129
Cheung KJ, Ewald AJ (2016) A collective route to metastasis: seeding by tumor cell clusters. Science 352:167–169
Cortes-Dericks L, Froment L, Boesch R et al (2014) Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. BMC Cancer 14:304
Cortes-Dericks L, Froment L, Kocher G et al (2016) Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines. Stem Cell Res Ther 7:25
Craighead JE, Akley NJ, Gould LB et al (1987) Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am J Pathol 129:448–462
Daubriac J, Fleury-Feith J, Kheuang L et al (2009) Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Cell Death Differ 16:1146–1155
Delage B, Fennell DA, Nicholson L et al (2010) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126:2762–2772
Deng XB, Xiao L, Wu Y et al (2015) Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. Int J Cancer 137:481–490
Desoize B, Jardillier J (2000) Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol 36:193–207
Dubessy C, Merlin JM, Marchal C et al (2000) Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol 36:179–192
Echeverry N, Ziltener G, Barbone D et al (2015) Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death Dis 6:e1757
Eguchi R, Fujita Y, Tabata C et al (2015) Inhibition of Src family kinases overcomes anoikis resistance induced by spheroid formation and facilitates cisplatin-induced apoptosis in human mesothelioma cells. Oncol Rep 34:2305–2310
Ernst A, Hofmann S, Ahmadi R et al (2009) Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res 15:6541–6550
Fjellbirkeland L, Bjerkvig R, Laerum OD (1995) Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture. Virchows Arch 426:169–178
Follo C, Barbone D, Richards WG et al (2016) Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome. Autophagy 12:1180–1194
Friedrich J, Seidel C, Ebner R et al (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4:309–324
Ghani FI, Yamazaki H, Iwata S et al (2011) Identification of cancer stem cell markers in human malignant mesothelioma cells. Biochem Biophys Res Commun 404:735–742
Gordon DJ, Milner AE, Beaney RP et al (1990) The increase in radioresistance of Chinese hamster cells cultured as spheroids is correlated to changes in nuclear morphology. Radiat Res 121:175–179
Hoda MA, Mohamed A, Ghanim B et al (2011) Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy. J Thorac Oncol 6:852–863
Jagirdar RM, Apostolidou E, Molyvdas PA et al (2016) Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent. Am J Phys Lung Cell Mol Phys 310:L489–L495
Katt ME, Placone AL, Wong AD et al (2016) In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol 4:12
Kim H, Phung Y, Ho M (2012) Changes in global gene expression associated with 3D structure of tumors: an ex vivo matrix-free mesothelioma spheroid model. PLoS One 7:e39556
Kim KU, Wilson AD, Abayasiriwardana KS et al (2005) A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am J Respir Cell Mol Biol 33:541–548
Kindler HL (2008) Systemic treatments for mesothelioma: standard and novel. Curr Treat Options in Oncol 9:171–179
Kobayashi H, Man S, Graham CH et al (1993) Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 90:3294–3298
Kunz-Schughart LA, Freyer JP, Hofstaedter F et al (2004) The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 9:273–285
Lao Z, Kelly CJ, Yang XY et al (2015) Improved methods to generate spheroid cultures from tumor cells, tumor cells & fibroblasts or tumor-fragments: microenvironment, microvesicles and miRNA. PLoS One 10:e0133895
Leek R, Grimes DR, Harris AL et al (2016) Methods: using three-dimensional culture (spheroids) as an in vitro model of tumour hypoxia. Adv Exp Med Biol 899:167–196
Lei H, Hofferberth SC, Liu R et al (2015) Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids. J Thorac Cardiovasc Surg 149:1417–1424. discussion 1424-1425
Liu S, Cheng H, Kwan W et al (2008) Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models. Mol Cancer Ther 7:11751–11761
Lobjois V, Frongia C, Jozan S et al (2009) Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids. Eur J Cancer 45:2402–2411
Manente AG, Pinton G, Zonca S et al (2015) Intracellular lactate-mediated induction of estrogen receptor beta (ERbeta) in biphasic malignant pleural mesothelioma cells. Oncotarget 6:25121–25134
Melaiu O, Stebbing J, Lombardo Y et al (2014) MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma. PLoS One 9:e85935
Menges CW, Kadariya Y, Altomare D et al (2014) Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res 74:1261–1271
Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592
Miselis NR, Wu ZJ, Van Rooijen N et al (2008) Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Mol Cancer Ther 7:788–799
Miselis NR, Lau BW, Wu Z et al (2011) Kinetics of host cell recruitment during dissemination of diffuse malignant peritoneal mesothelioma. Cancer Microenviron 4:39–50
Napolitano AP, Chai P, Dean DM et al (2007) Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng 13:2087–2094
Nath S, Devi GR (2016) Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther 163:94–108
Nishikawa S, Tanaka A, Matsuda A et al (2014) A molecular targeting against nuclear factor-kappaB, as a chemotherapeutic approach for human malignant mesothelioma. Cancer Med 3:416–425
Pasdar EA, Smits M, Stapelberg M et al (2015) Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents. PLoS One 10:e0119549
Pastrana E, Silva-Vargas V, Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8:486–498
Pease JC, Brewer M, Tirnauer JS (2012) Spontaneous spheroid budding from monolayers: a potential contribution to ovarian cancer dissemination. Biol Open 1:622–628
Raphael J, Massard C, Gong IY et al (2015) Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma. Cancer Biomark 15:151–156
Ruppen J, Cortes-Dericks L, Marconi E et al (2014) A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids. Lab Chip 14:1198–1205
Schelch K, Hoda MA, Klikovits T et al (2014) Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy. Am J Respir Crit Care Med 190:763–772
Shield K, Ackland ML, Ahmed N et al (2009) Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 113:143–148
Stapelberg M, Gellert N, Swettenham E et al (2005) Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress. J Biol Chem 280:25369–25376
Steadman K, Stein WD, Litman T et al (2008) PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors. Cell Cycle 7:818–829
Sutherland RM, McCredie JA, Inch WR (1971) Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46:113–120
Varghese S, Whipple R, Martin SS et al (2012) Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis. PLoS One 7:e52825
Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644
Wangpaichitr M, Wu C, Bigford G et al (2014) Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma. Anticancer Res 34:6991–6999
Weiswald LB, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17:1–15
West CM, Sutherland RM (1987) The radiation response of a human colon adenocarcinoma grown in monolayer, as spheroids, and in nude mice. Radiat Res 112:105–115
Whitaker D (1977) Cell aggregates in malignant mesothelioma. Acta Cytol 21:236–239
Wilson SM, Barbone D, Yang TM et al (2008) mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. Am J Respir Cell Mol Biol 39:576–583
Xiang X, Phung Y, Feng M et al (2011) The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One 6:e14640
Yang TM, Barbone D, Fennell DA et al (2009) Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Am J Respir Cell Mol Biol 41:14–23
Yoneda K, Tanaka F, Kondo N et al (2014) Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). Ann Surg Oncol 21(Suppl 4):S472–S480
Acknowledgments
We wish to acknowledge the funding sources that made this work possible, including the Department of Defense, the Mesothelioma Foundation (MARF), and the Simmons Foundation (a private, nonprofit organization founded by the Simmons Law Firm).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Broaddus, V.C., Follo, C., Barbone, D. (2017). 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival. In: Testa, J. (eds) Asbestos and Mesothelioma. Current Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-53560-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-53560-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53558-6
Online ISBN: 978-3-319-53560-9
eBook Packages: MedicineMedicine (R0)